Acclean Chlorhexidine Gluconate 0.12% Oral Rinse Liquid
Product Images NDC 0116-4075

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Acclean Chlorhexidine Gluconate 0.12% Oral Rinse (NDC 0116-4075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xttrium Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Hs16 Drug Facts 1

Hs16 Drug Facts 1
This is a product description of ACCLEAN® which contains Chiorhexidine Gluconate, used as a disinfectant. The product contains 1,1'-hexamtiy-e s 5-p-chltopheny)tiguande, PEG-40, cxbitan discseaate, vor, sofm saocterin,and FDEC Ble o, Chihexidin. The product is commonly used by pharmacists and has a natural pH of 7. The chemical structure of Chiorhexidine Gluconate is also mentioned. No other information is available.*
FDA Label Image

Hs16 Drug Facts 2

Hs16 Drug Facts 2
CLINICAL PHARMACOLOGY: Chlrohexidine provides antibacterial properties. It has shown a reduction in certain bacteria ranging from 54-07%. The use of chlrohexidine does not result in any significant changes to bacterial enzymes overgrowth or microbial system. Pharmacokinetics: Chlrohexidine is absorbed from the intestinal tract but its effect on periodontitis has not been determined. It can cause staining of surfaces and tongue and may increase supragingival calculi. It should be used with caution when prescribing. Indication: Chlrohexidine is indicated for the treatment of gingivitis and pericoronitis. Precautions: It should be used with caution for pregnant and nursing women. The drug can cause staining of surfaces and tongue. It may not be suitable for patients having calculus and patients who accumulate plaque. The drug may require additional measures for complete removal of plaque in some cases. Contraindications: It should not be used for patients who are known to have hypersensitivity to chlrohexidine. Warnings: The effect of chlrohexidine on subgingival calculus has not been determined. It should not be used when prescribing or with anterior surfaces.*
FDA Label Image

Hs16 Drug Facts 3

Hs16 Drug Facts 3
FDA Label Image

Hs16 Pdp

Hs16 Pdp
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.